Katharina Baur

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Newly Diagnosed

Mesenchymal Stem Cells

Prognostic Factors

Top Venues

Cancer immunology research

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes. Cancer immunology research 12 (7) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes. Cancer immunology research (2024)
Katharina Baur, Andreas S Buser, Lukas T Jeker, Nina Khanna, Heinz Läubli, Dominik Heim, Jan C Dirks, Corinne C Widmer, Thomas Volken, Jakob R Passweg, Andreas Holbro
CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas. Bone marrow transplantation (2023)